Org.nr 990 646 066 2017 → 2018 Year-over-year analysis

NYKODE THERAPEUTICS ASA: årsregnskap 2018 vs 2017

Grew 23% on revenue

approved 2019-05-13; registry 2019-06-26; journal 2019 537270

Summary

What changed

Comparing Årsregnskap 2018 with 2017 for NYKODE THERAPEUTICS ASA. Revenue 9.76m NOK → 12.04m NOK (+23.3%). Equity 203.53m NOK → 140.07m NOK.

On the constructive side: revenue rose; owners injected capital. Pressures included: equity eroded; cash fell.

Also worth watching: book investments changed. All figures are taken from the published annual accounts for NYKODE THERAPEUTICS ASA.

At a glance

Revenue

9.76m NOK 12.04m NOK

+23.3%

Equity

203.53m NOK 140.07m NOK

-31.2%

Cash

40.28m NOK 32.44m NOK

-19.5%

Total assets

214.47m NOK 153.34m NOK

-28.5%

↑
Revenue rose

Operating income / revenue moved from 9.76m NOK to 12.04m NOK (+23.3% YoY). Calculated
↑
Owners injected capital

Paid-in equity rose 289.86m NOK → 290.20m NOK (+336.9k NOK). Reported fact

↓
Equity eroded

Book equity 203.53m NOK → 140.07m NOK (equity ratio 94.9% → 91.3%). Calculated
↓
Cash fell

Bank deposits 40.28m NOK → 32.44m NOK (-19.5% YoY). Calculated

·
Book investments changed

Investment / intangible book value 45.9k NOK → 74.6k NOK. Reported fact